Literature DB >> 27100941

The problems and pitfalls in systemic lupus erythematosus drug discovery.

Ignasi Rodríguez-Pintó1, Gerard Espinosa1, Ricard Cervera1.   

Abstract

Entities:  

Keywords:  Systemic lupus erythematosus; clinical trial; drug approval; epidemiologic methods; pragmatic trial

Mesh：

Year:  2016        PMID： 27100941     DOI： 10.1080/17460441.2016.1181056

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  5 in total

1.  Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial.

Authors:  Stephen McDonald; Sean Yiu; Li Su; Caroline Gordon; Matt Truman; Laura Lisk; Neil Solomons; Ian N Bruce
Journal:  Lupus Sci Med       Date:  2022-05

2.  Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus.

Authors:  Winston A Haynes; D James Haddon; Vivian K Diep; Avani Khatri; Erika Bongen; Gloria Yiu; Imelda Balboni; Christopher R Bolen; Rong Mao; Paul J Utz; Purvesh Khatri
Journal:  JCI Insight       Date:  2020-02-27

Review 3.  Modelling clinical systemic lupus erythematosus: similarities, differences and success stories.

Authors:  Teja Celhar; Anna-Marie Fairhurst
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

Review 4.  Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.

Authors:  I-Tsu Chyuan; Hong-Tai Tzeng; Ji-Yih Chen
Journal:  Cells       Date:  2019-08-23       Impact factor: 6.600

Review 5.  Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments.

Authors:  Zahi Touma; Dafna D Gladman
Journal:  Lupus Sci Med       Date:  2017-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.